Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.
Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ; Cancer Prevention Network.
Reid JM, et al. Among authors: limburg pj.
Cancer Prev Res (Phila). 2011 Mar;4(3):347-53. doi: 10.1158/1940-6207.CAPR-10-0313.
Cancer Prev Res (Phila). 2011.
PMID: 21372034
Free PMC article.
Clinical Trial.